Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	2.95e-22	114	123	19	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	1.59e-21	124	123	19	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	1.14e-20	137	123	19	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	7.81e-18	192	123	19	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	1.91e-08	654	123	19	GO:0008233
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRA1 GABRA2 GABRA3 GABRA6	4.38e-07	11	123	4	GO:0008503
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRA1 GABRA2 GABRA3 GABRA6	3.92e-06	18	123	4	GO:0022851
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRA1 GABRA2 GABRA3 GABRA6	4.95e-06	19	123	4	GO:0004890
GeneOntologyMolecularFunction	GABA receptor activity	GABRA1 GABRA2 GABRA3 GABRA6	9.20e-06	22	123	4	GO:0016917
GeneOntologyMolecularFunction	diazepam binding	GABRA1 GABRA6	1.12e-04	3	123	2	GO:0050809
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	FLT3 PDGFRA AVPR1A GPR34 CLEC1B GPRC6A PKD1L3 NID1 ADGRE5 TAS2R40 KIR2DL1 TAS2R20 KIR2DS1 KIR2DS4 KIR2DS5 IL23R GABRA1 GABRA2 GABRA3 GABRA6	2.22e-04	1353	123	20	GO:0004888
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GABRA1 GABRA2 GABRA3 GABRA6	2.54e-04	50	123	4	GO:0099095
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE1 SYNE2	3.72e-04	5	123	2	GO:0140444
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GABRA1 GABRA2 GABRA3	4.20e-04	24	123	3	GO:0099507
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GABRA1 GABRA2 GABRA3 GABRA6	4.21e-04	57	123	4	GO:1904315
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRA1 GABRA2 GABRA3 GABRA6	5.12e-04	60	123	4	GO:0099529
GeneOntologyMolecularFunction	transmitter-gated channel activity	GABRA1 GABRA2 GABRA3 GABRA6	6.94e-04	65	123	4	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GABRA1 GABRA2 GABRA3 GABRA6	6.94e-04	65	123	4	GO:0022824
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	FLT3 PDGFRA	7.75e-04	7	123	2	GO:0005021
GeneOntologyMolecularFunction	N-acylsphingosine amidohydrolase activity	ASAH2 ASAH2B	7.75e-04	7	123	2	GO:0017040
GeneOntologyMolecularFunction	taste receptor activity	PKD1L3 TAS2R40 TAS2R20	1.09e-03	33	123	3	GO:0008527
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	GABRA1 GABRA2 GABRA3 GABRA6	1.19e-03	75	123	4	GO:0098960
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GABRA1 GABRA2 GABRA3 GABRA6	1.31e-03	77	123	4	GO:0005230
GeneOntologyMolecularFunction	chloride channel activity	GABRA1 GABRA2 GABRA3 GABRA6	1.97e-03	86	123	4	GO:0005254
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	1.20e-21	125	124	19	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	1.97e-20	144	124	19	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 BAZ1B USP17L5 ZC3HC1 USP17L10 USP17L19 KBTBD2 USP17L18 KLHL3 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 KLHL18 USP17L15 HERC5 USP17L8 USP17L13	4.59e-09	1074	124	25	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 ZC3HC1 USP17L10 USP17L19 KBTBD2 USP17L18 KLHL3 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 KLHL18 USP17L15 HERC5 USP17L8 USP17L13	6.49e-09	1009	124	24	GO:0070647
GeneOntologyBiologicalProcess	protein deubiquitination involved in ubiquitin-dependent protein catabolic process	USP17L24 USP17L6P ZRANB1	1.16e-05	8	124	3	GO:0071947
GeneOntologyBiologicalProcess	inhibitory synapse assembly	GABRA1 GABRA2 GABRA3 GABRA6	3.02e-05	30	124	4	GO:1904862
GeneOntologyBiologicalProcess	gamma-aminobutyric acid signaling pathway	GABRA1 GABRA2 GABRA3 GABRA6	5.64e-05	35	124	4	GO:0007214
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 USP17L4 USP17L12 USP17L1 PDGFRA USP17L20 USP17L11 SYNE1 PIEZO1 USP17L5 USP17L10 EXT2 USP17L19 USP17L18 NBAS USP17L17 SYNE2 USP17L6P USP17L3 NR3C2 G6PC2 USP17L22 USP17L15 USP17L8 USP17L13	2.19e-07	1327	124	25	GO:0042175
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 USP17L4 USP17L12 USP17L1 PDGFRA USP17L20 USP17L11 PIEZO1 USP17L5 USP17L10 EXT2 USP17L19 USP17L18 NBAS USP17L17 SYNE2 USP17L6P USP17L3 NR3C2 G6PC2 USP17L22 USP17L15 USP17L8 USP17L13	5.24e-07	1293	124	24	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 USP17L4 USP17L12 USP17L1 PDGFRA USP17L20 USP17L11 PIEZO1 USP17L5 USP17L10 EXT2 USP17L19 USP17L18 NBAS USP17L17 SYNE2 USP17L6P USP17L3 NR3C2 G6PC2 USP17L22 USP17L15 USP17L8 USP17L13	5.69e-07	1299	124	24	GO:0098827
GeneOntologyCellularComponent	GABA-A receptor complex	GABRA1 GABRA2 GABRA3 GABRA6	4.27e-06	19	124	4	GO:1902711
GeneOntologyCellularComponent	leading edge membrane	PDE9A PIEZO1 RAB34 SYNE2 ADGRE5 GABRA1 GABRA2 GABRA3 GABRA6	4.59e-06	210	124	9	GO:0031256
GeneOntologyCellularComponent	GABA receptor complex	GABRA1 GABRA2 GABRA3 GABRA6	6.53e-06	21	124	4	GO:1902710
GeneOntologyCellularComponent	cell projection membrane	TRPM6 PDE9A PIEZO1 ADCY3 RAB34 SYNE2 GABRA1 GABRA2 GABRA3 GABRA6	2.52e-04	431	124	10	GO:0031253
GeneOntologyCellularComponent	dendrite membrane	GABRA1 GABRA2 GABRA3 GABRA6	3.41e-04	56	124	4	GO:0032590
GeneOntologyCellularComponent	chloride channel complex	GABRA1 GABRA2 GABRA3 GABRA6	3.65e-04	57	124	4	GO:0034707
GeneOntologyCellularComponent	postsynaptic specialization membrane	ELFN1 LRP1 GABRA1 GABRA2 GABRA3 GABRA6	1.28e-03	201	124	6	GO:0099634
GeneOntologyCellularComponent	neuron projection membrane	GABRA1 GABRA2 GABRA3 GABRA6	1.44e-03	82	124	4	GO:0032589
GeneOntologyCellularComponent	microtubule organizing center attachment site	SYNE1 SYNE2	1.85e-03	11	124	2	GO:0034992
GeneOntologyCellularComponent	meiotic nuclear membrane microtubule tethering complex	SYNE1 SYNE2	1.85e-03	11	124	2	GO:0034993
GeneOntologyCellularComponent	insulin-responsive compartment	DENND4C LRP1	1.85e-03	11	124	2	GO:0032593
GeneOntologyCellularComponent	nuclear membrane protein complex	SYNE1 SYNE2	1.85e-03	11	124	2	GO:0106083
GeneOntologyCellularComponent	nuclear membrane microtubule tethering complex	SYNE1 SYNE2	1.85e-03	11	124	2	GO:0106094
GeneOntologyCellularComponent	receptor complex	FLT3 PDGFRA PKD1L3 LRP1 NR3C2 IL23R GABRA1 GABRA2 GABRA3 GABRA6	2.44e-03	581	124	10	GO:0043235
GeneOntologyCellularComponent	postsynaptic membrane	COMT SYNE1 ELFN1 LRP1 GABRA1 GABRA2 GABRA3 GABRA6	2.90e-03	405	124	8	GO:0045211
GeneOntologyCellularComponent	GABA-ergic synapse	NR3C2 GABRA1 GABRA2 GABRA3 GABRA6	2.97e-03	164	124	5	GO:0098982
GeneOntologyCellularComponent	cell leading edge	PDE9A PIEZO1 RAB34 SYNE2 ADGRE5 GABRA1 GABRA2 GABRA3 GABRA6	2.99e-03	500	124	9	GO:0031252
GeneOntologyCellularComponent	ISWI-type complex	BAZ1B SMARCA1	3.03e-03	14	124	2	GO:0031010
Domain	HABP4_PAI-RBP1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	4.51e-24	16	119	12	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	4.51e-24	16	119	12	IPR006861
Domain	UCH	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	6.21e-21	71	119	16	PF00443
Domain	USP_2	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	6.21e-21	71	119	16	PS00973
Domain	USP_3	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.94e-21	72	119	16	PS50235
Domain	USP_dom	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.94e-21	72	119	16	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	7.94e-21	72	119	16	IPR001394
Domain	USP_CS	USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	9.53e-20	66	119	15	IPR018200
Domain	USP_1	USP17L21 USP17L4 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.51e-19	70	119	15	PS00972
Domain	GABAAa_rcpt	GABRA1 GABRA2 GABRA3 GABRA6	2.33e-08	6	119	4	IPR001390
Domain	GABAA/Glycine_rcpt	GABRA1 GABRA2 GABRA3 GABRA6	1.26e-05	23	119	4	IPR006028
Domain	Ceramidse_alk_C	ASAH2 ASAH2B	4.03e-05	2	119	2	PF17048
Domain	NEUT/ALK_ceramidase_C	ASAH2 ASAH2B	4.03e-05	2	119	2	IPR031331
Domain	Ceramidase_alk	ASAH2 ASAH2B	4.03e-05	2	119	2	IPR006823
Domain	Ldl_recept_b	EGF LRP1 NID1	8.72e-05	14	119	3	PF00058
Domain	LDLRB	EGF LRP1 NID1	8.72e-05	14	119	3	PS51120
Domain	LY	EGF LRP1 NID1	1.09e-04	15	119	3	SM00135
Domain	LDLR_classB_rpt	EGF LRP1 NID1	1.09e-04	15	119	3	IPR000033
Domain	Neurotransmitter_ion_chnl_CS	GABRA1 GABRA2 GABRA3 GABRA6	1.91e-04	45	119	4	IPR018000
Domain	Neur_chan_memb	GABRA1 GABRA2 GABRA3 GABRA6	2.08e-04	46	119	4	PF02932
Domain	ig	FLT3 PDGFRA KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.17e-04	190	119	7	PF00047
Domain	Immunoglobulin	FLT3 PDGFRA KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.17e-04	190	119	7	IPR013151
Domain	Neur_chan_LBD	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	PS00236
Domain	Neurotrans-gated_channel_TM	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	IPR006029
Domain	-	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	2.70.170.10
Domain	Neur_channel	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	IPR006201
Domain	Neur_chan_lig-bd	GABRA1 GABRA2 GABRA3 GABRA6	2.26e-04	47	119	4	IPR006202
Domain	KASH	SYNE1 SYNE2	2.40e-04	4	119	2	PF10541
Domain	KASH	SYNE1 SYNE2	2.40e-04	4	119	2	IPR012315
Domain	KASH	SYNE1 SYNE2	2.40e-04	4	119	2	PS51049
Domain	KASH	SYNE1 SYNE2	2.40e-04	4	119	2	SM01249
Domain	Alpha_kinase	TRPM6 ALPK2	5.94e-04	6	119	2	PF02816
Domain	ALPHA_KINASE	TRPM6 ALPK2	5.94e-04	6	119	2	PS51158
Domain	Alpha_kinase	TRPM6 ALPK2	5.94e-04	6	119	2	SM00811
Domain	MHCK_EF2_kinase	TRPM6 ALPK2	5.94e-04	6	119	2	IPR004166
Domain	Tyr_kinase_CSF1/PDGF_rcpt	FLT3 PDGFRA	5.94e-04	6	119	2	IPR016243
Domain	Tyr_kinase_rcpt_3_CS	FLT3 PDGFRA	1.10e-03	8	119	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT3 PDGFRA	1.10e-03	8	119	2	PS00240
Domain	IG	FLT3 PDGFRA FCRL1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 ALPK2	1.50e-03	421	119	9	SM00409
Domain	Ig_sub	FLT3 PDGFRA FCRL1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 ALPK2	1.50e-03	421	119	9	IPR003599
Domain	-	EGF LRP1 NID1	1.95e-03	39	119	3	2.120.10.30
Domain	-	EGF NID1	2.13e-03	11	119	2	2.40.155.10
Domain	GFP-like	EGF NID1	2.13e-03	11	119	2	IPR023413
Domain	EGF_CA	EGF LRP1 NID1 ADGRE5	2.23e-03	86	119	4	PF07645
Domain	BTB-kelch_protein	KBTBD2 KLHL3 KLHL18	2.58e-03	43	119	3	IPR017096
Domain	6-blade_b-propeller_TolB-like	EGF LRP1 NID1	3.14e-03	46	119	3	IPR011042
Domain	EGF_Ca-bd_CS	EGF LRP1 NID1 ADGRE5	3.44e-03	97	119	4	IPR018097
Domain	EGF_CA	EGF LRP1 NID1 ADGRE5	3.70e-03	99	119	4	PS01187
Domain	ASX_HYDROXYL	EGF LRP1 NID1 ADGRE5	3.84e-03	100	119	4	PS00010
Domain	IG_LIKE	FLT3 PDGFRA FCRL1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 ALPK2	4.20e-03	491	119	9	PS50835
Domain	EGF-type_Asp/Asn_hydroxyl_site	EGF LRP1 NID1 ADGRE5	4.72e-03	106	119	4	IPR000152
Domain	Helicase_C	ERCC3 DDX52 DHX38 SMARCA1	4.88e-03	107	119	4	PF00271
Domain	HELICc	ERCC3 DDX52 DHX38 SMARCA1	4.88e-03	107	119	4	SM00490
Domain	Ig-like_dom	FLT3 PDGFRA FCRL1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5 ALPK2	4.91e-03	503	119	9	IPR007110
Domain	Helicase_C	ERCC3 DDX52 DHX38 SMARCA1	5.05e-03	108	119	4	IPR001650
Domain	HELICASE_CTER	ERCC3 DDX52 DHX38 SMARCA1	5.21e-03	109	119	4	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC3 DDX52 DHX38 SMARCA1	5.21e-03	109	119	4	PS51192
Domain	DEXDc	ERCC3 DDX52 DHX38 SMARCA1	5.21e-03	109	119	4	SM00487
Domain	Helicase_ATP-bd	ERCC3 DDX52 DHX38 SMARCA1	5.38e-03	110	119	4	IPR014001
Domain	LH2	PKD1L3 LOXHD1	5.76e-03	18	119	2	SM00308
Domain	Kelch	KBTBD2 KLHL3 KLHL18	6.03e-03	58	119	3	SM00612
Domain	Gal_Oxase/kelch_b-propeller	KBTBD2 KLHL3 KLHL18	6.33e-03	59	119	3	IPR011043
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.89e-26	45	101	17	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.52e-14	191	101	17	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	RAF1 USP17L21 USP17L4 USP17L12 USP17L1 PDGFRA USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 EGF USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.22e-14	318	101	20	MM15278
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.81e-13	221	101	17	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	3.67e-13	262	101	18	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	3.46e-12	299	101	18	M27574
Pathway	BIOCARTA_FLUMAZENIL_PATHWAY	GABRA1 GABRA2 GABRA3 GABRA6	3.04e-07	9	101	4	M22034
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3 GABRA6	5.04e-07	10	101	4	M477
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3	4.13e-05	10	101	3	MM1401
Pathway	WP_GABA_RECEPTOR_SIGNALING	GABRA1 GABRA2 GABRA3 GABRA6	6.73e-05	31	101	4	M39369
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	ADCY3 GABRA1 GABRA2 GABRA3 GABRA6	6.83e-05	60	101	5	MM15708
Pathway	REACTOME_GABA_RECEPTOR_ACTIVATION	ADCY3 GABRA1 GABRA2 GABRA3 GABRA6	6.83e-05	60	101	5	M976
Pathway	WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION	GABRA1 GABRA2 GABRA3 GABRA6	1.52e-04	38	101	4	M39854
Pathway	WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS	RAF1 EGF GABRA1 GABRA2 GABRA3 GABRA6	2.10e-04	119	101	6	M48309
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L12 USP17L1 STAG1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 KLHL3 RAB34 USP17L17 USP17L6P USP17L3 NR3C2 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	2.78e-04	1389	101	22	MM15307
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.18e-04	88	101	5	M16004
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	RAF1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.49e-04	137	101	6	M5669
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L12 USP17L1 STAG1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 KLHL3 RAB34 USP17L17 USP17L3 NR3C2 USP17L22 ZRANB1 USP17L15 USP17L8 USP17L13	6.39e-04	1475	101	22	M19806
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.30e-39	21	125	17	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.32e-38	22	125	17	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.04e-37	24	125	17	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.46e-37	25	125	17	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.72e-36	26	125	17	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.76e-36	33	125	18	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.85e-36	34	125	18	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.20e-35	35	125	18	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.20e-35	35	125	18	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.40e-35	36	125	18	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.49e-35	29	125	17	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.65e-35	37	125	18	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	8.00e-30	50	125	17	31806660
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 RFX4 USP17L18 EGF SLCO1C1 USP17L17 SMARCA1 USP17L6P USP17L3 LY75 USP17L22 USP17L15 USP17L8 USP17L13	3.91e-15	674	125	22	37196079
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.96e-13	10	125	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.73e-12	12	125	6	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	5.60e-12	14	125	6	11793228
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.07e-11	8	125	5	18681957
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	4.99e-11	19	125	6	28067227
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.51e-10	11	125	5	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.29e-10	12	125	5	20371502
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.29e-10	12	125	5	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.29e-10	12	125	5	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.29e-10	12	125	5	20137308
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.96e-10	13	125	5	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.96e-10	13	125	5	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.96e-10	13	125	5	18687225
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	7.93e-10	5	125	4	19410616
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.08e-09	14	125	5	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.08e-09	14	125	5	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.08e-09	14	125	5	15896204
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.61e-09	15	125	5	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	16403292
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.34e-09	16	125	5	20210919
Pubmed	GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.	GABRA1 GABRA2 GABRA3 GABRA6	2.37e-09	6	125	4	20457185
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	20650299
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	20483367
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19169284
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	3.31e-09	17	125	5	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	4.57e-09	18	125	5	19846535
Pubmed	Developmental changes in GABA receptor subunit composition within the gonadotrophin-releasing hormone-1 neuronal system.	GABRA1 GABRA2 GABRA3 GABRA6	5.52e-09	7	125	4	16101898
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.18e-09	19	125	5	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.18e-09	19	125	5	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.18e-09	19	125	5	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	6.18e-09	19	125	5	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	8.22e-09	20	125	5	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	8.22e-09	20	125	5	20426625
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.08e-08	21	125	5	19861144
Pubmed	gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties.	GABRA1 GABRA2 GABRA3 GABRA6	1.10e-08	8	125	4	8175718
Pubmed	GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1.	GABRA1 GABRA2 GABRA3 GABRA6	1.10e-08	8	125	4	11528422
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 FLT3 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	1.25e-08	119	125	8	28625976
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.39e-08	22	125	5	20492596
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L1 USP17L6P USP17L3 ZRANB1 USP17L15 USP17L8	1.82e-08	81	125	7	12838346
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 KIAA0232 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	6.54e-24	79	125	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 KIAA0232 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	6.50e-17	222	125	15	chr4p16
Cytoband	19q13.4	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	2.65e-06	79	125	5	19q13.4
Cytoband	8p23.1	USP17L4 USP17L1 USP17L3 USP17L8	8.61e-04	154	125	4	8p23.1
Cytoband	4p12	NIPAL1 GABRA2	1.35e-03	20	125	2	4p12
Cytoband	1p22	DPYD CTBS	1.35e-03	20	125	2	1p22
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.01e-08	18	77	5	620
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRA1 GABRA2 GABRA3 GABRA6	1.12e-06	19	77	4	563
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	FLT3 PDGFRA FCRL1 LRP1 ADGRE5 KIR2DL1 KIR2DS1 LY75 KIR2DS4 KIR2DS5	6.44e-06	394	77	10	471
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE2	1.07e-04	4	77	2	1252
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 TTPA USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.90e-25	86	123	18	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.06e-21	112	123	17	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.63e-18	160	123	17	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L4 EOGT USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 PPM1B USP17L18 USP17L17 USP17L6P USP17L3 TMEM19 USP17L22 USP17L15 USP17L8 USP17L13	2.48e-11	647	123	20	MM981
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L4 EOGT USP17L12 USP17L1 USP17L20 ACAD9 USP17L11 ASAH2 USP17L5 USP17L10 USP17L19 PPM1B USP17L18 USP17L17 USP17L6P USP17L3 TMEM19 USP17L22 ZRANB1 USP17L15 ASAH2B USP17L8 USP17L13	2.37e-09	1226	123	24	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 ABHD2 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 TMEM19 USP17L22 USP17L15 USP17L8 USP17L13	6.17e-07	1072	123	19	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 ZNF850 USP17L18 NBAS USP17L17 USP17L6P USP17L3 NID1 USP17L22 USP17L15 USP17L8 USP17L13	7.69e-07	1198	123	20	MM1062
Coexpression	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	STAG1 SLC6A16 SYNE1 FABP7 JAK1 VPS13D PLEKHG3	4.15e-05	197	123	7	M5475
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS5	8.31e-05	49	123	4	M40909
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ASAH2 SYNE1 RFX4 PRDM1 SYNE2 IL23R	6.30e-06	175	115	6	cc2428150987911d0d382e8177918724aa69f85c
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ASAH2 SYNE1 RFX4 PRDM1 SYNE2 IL23R	6.50e-06	176	115	6	003076f1a983409ddf31b9c19e61c1facdd72566
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNMB2 FLT3 LHFPL3 PRDM1 ELFN1 NIPAL1	8.13e-06	183	115	6	439b1d1373b7cc73d65f3b59037a6def7cf8f4ba
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA TNMD SLCO1C1 LRP1 NID1 GABRA3	8.92e-06	186	115	6	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1 GABRA3	9.48e-06	188	115	6	7471c194276161422326647f09022e94f3d1640c
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1 GABRA3	9.48e-06	188	115	6	053c251d3ddbeb866f34565aefca4535517b4387
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 LHFPL3 KLHL3 NR3C2 ARHGEF3 GABRA2	1.01e-05	190	115	6	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMB2 ABHD2 DENND4C SLC2A5 NIPAL1 G6PC2	1.04e-05	191	115	6	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1 GABRA3	1.04e-05	191	115	6	ece87127f85939e61b1048d968ed96f0e87c3a79
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1 GABRA3	1.04e-05	191	115	6	478e8341ee03b05501e2233e02cef5f97492c95d
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMB2 ABHD2 DENND4C SLC2A5 NIPAL1 G6PC2	1.07e-05	192	115	6	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	Leuk-UTI-Lymphocyte-T_NK-NK\|Leuk-UTI / Disease, Lineage and Cell Type	SYNE1 PRDM1 JAK1 PLEKHG3 SYNE2 KIR2DL1	1.13e-05	194	115	6	36afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA ADCY3 LOXHD1 LRP1 NID1 ADGRE5	1.20e-05	196	115	6	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD16\|Liver / Manually curated celltypes from each tissue	SYNE1 JAK1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.20e-05	196	115	6	e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA ADCY3 LOXHD1 LRP1 NID1 ADGRE5	1.20e-05	196	115	6	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	SYNE1 JAK1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.20e-05	196	115	6	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA ADCY3 LOXHD1 LRP1 NID1 ADGRE5	1.24e-05	197	115	6	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA ADCY3 LOXHD1 LRP1 NID1 ADGRE5	1.24e-05	197	115	6	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA ADCY3 LOXHD1 LRP1 NID1 ADGRE5	1.24e-05	197	115	6	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	severe-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABHD2 SYNE1 JAK1 PLEKHG3 KIR2DL1 KIR2DS4	1.27e-05	198	115	6	6ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ABHD2 SYNE1 JAK1 PLEKHG3 SYNE2 ARHGEF3	1.27e-05	198	115	6	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	mild-Lymphocytic-NK_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYNE1 JAK1 SYNE2 KIR2DL1 ARHGEF3 KIR2DS4	1.27e-05	198	115	6	dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCell	(0)_NK_FCGR3Apos\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PRDM1 PLEKHG3 SYNE2 ADGRE5 KIR2DL1 ARHGEF3	1.27e-05	198	115	6	13f10f9233fc1523f0da2d9d59f3ced9c51a603a
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 PRDM1 JAK1 PLEKHG3 SYNE2 ADGRE5	1.27e-05	198	115	6	2fdb92b198ba24e326e90479fd024400d956fb32
ToppCell	(0)_NK_cells-(0)_NK_FCGR3Apos\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SYNE1 PRDM1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.27e-05	198	115	6	eba39656c6f699ab297b652ded8cb9727b49593c
ToppCell	control-Lymphocytic-NK_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SYNE1 JAK1 SYNE2 KIR2DL1 ARHGEF3 KIR2DS4	1.27e-05	198	115	6	1c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL\|Int-URO / Disease, condition lineage and cell class	ASAH2 SYNE1 DENND4C PRDM1 SYNE2 ASAH2B	1.27e-05	198	115	6	717735d755745439f97ba1b71785c73945dfa9c5
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ABHD2 SYNE1 JAK1 PLEKHG3 SYNE2 ARHGEF3	1.27e-05	198	115	6	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA ABHD2 SYNE1 LHFPL3 TACC2 LRP1	1.31e-05	199	115	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SYNE1 JAK1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.31e-05	199	115	6	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA ABHD2 SYNE1 LHFPL3 TACC2 LRP1	1.31e-05	199	115	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDGFRA ABHD2 SYNE1 LHFPL3 TACC2 LRP1	1.31e-05	199	115	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SYNE1 JAK1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.31e-05	199	115	6	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KCNMB2 FLT3 LHFPL3 PRDM1 RAB34 ELFN1	1.35e-05	200	115	6	6a44439e4a7ce3627271375b04cfcfb9467218f4
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	SYNE1 JAK1 PLEKHG3 SYNE2 KIR2DL1 ARHGEF3	1.35e-05	200	115	6	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KCNMB2 FLT3 LHFPL3 PRDM1 RAB34 ELFN1	1.35e-05	200	115	6	8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK\|Leuk-UTI / Disease, condition lineage and cell class	SYNE1 PRDM1 JAK1 PLEKHG3 SYNE2 KIR2DL1	1.35e-05	200	115	6	bb37fed4872e71f413ae7c4aa12586fa31075334
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KCNMB2 FLT3 LHFPL3 PRDM1 RAB34 ELFN1	1.35e-05	200	115	6	cb1f4b0d66da5b0466ff17b29e7034d451d93e4f
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DPYD PDGFRA LHFPL3 FABP7 TNS3	2.48e-05	133	115	5	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 AVPR1A GPRC6A NR3C2 ARHGEF3	4.84e-05	153	115	5	9b6675ace8a83c8d446b722301d0ec4e6840f3fc
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 AVPR1A KLHL3 EGF GABRA2	6.34e-05	162	115	5	36ddebe3bb172c992739353b7b049b2dde98b559
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZWILCH PDE9A PRDM1 NBAS SYNE2	6.53e-05	163	115	5	4dfd408aa700e307478ee35f6b902f68719d8d9e
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16\|GI_small-bowel / Manually curated celltypes from each tissue	AVPR1A SYNE1 PLEKHG3 KIR2DL1 TAS2R20	8.19e-05	171	115	5	1ee505b91f15191d294a5d491ecdf154c08b8622
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 KRT85 FABP7 NIPAL1 LY75	8.42e-05	172	115	5	c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT3 KRT85 FABP7 NIPAL1 LY75	8.42e-05	172	115	5	48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e
ToppCell	facs-Lung-EPCAM-18m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 KRT85 FABP7 NIPAL1 LY75	8.42e-05	172	115	5	7c085c02b59e24e2a2cd393b5e692f9fb19257fe
ToppCell	droplet-Heart-nan-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COMT PDGFRA CST9 LRP1 GABRA3	8.89e-05	174	115	5	cf4e0567f2a4ebe5534046b1c091af59b55bdc4f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 SLCO1C1 LRP1 NID1	9.13e-05	175	115	5	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA KRT85 LHFPL3 FABP7 LRP1	9.13e-05	175	115	5	d67c77eee979ad029e7545f383326f0ff77c6e5f
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 DHX38 ARFGEF1 SYNE2 LRP1	9.13e-05	175	115	5	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA KRT85 LHFPL3 FABP7 LRP1	9.13e-05	175	115	5	1d1cdbf3221b03e24eae38afd57cbd6736b37a53
ToppCell	facs-Lung-EPCAM-3m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 RAB34 NIPAL1 LY75 ALPK2	9.63e-05	177	115	5	d445167dae956e641386f84ab3ae9f47c089e09a
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	PDGFRA SYNE1 LRP1 NID1 ALPK2	9.89e-05	178	115	5	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAG1 SYNE1 BAZ1B SYNE2 NR3C2	9.89e-05	178	115	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 RAB34 NIPAL1 LY75 ALPK2	9.89e-05	178	115	5	0b456ac768e026c3ecd5a9a4f43d6f126e7685a1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 GABRA2	1.02e-04	179	115	5	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 SLCO1C1 LRP1 NID1	1.07e-04	181	115	5	a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 SLCO1C1 LRP1 NID1	1.07e-04	181	115	5	526e858a848470b6d2d5248788004d9735ed3add
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 GABRA2	1.10e-04	182	115	5	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 AVPR1A KLHL3 EGF GABRA2	1.13e-04	183	115	5	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A RFX4 TTPA FABP7 GABRA2	1.13e-04	183	115	5	25c96df8ea0c7bbedbb7699ee84ad6234d19cba8
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.16e-04	184	115	5	278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNMB2 FLT3 LHFPL3 PRDM1 ELFN1	1.16e-04	184	115	5	23515c28e1f42aab29cef9e5b4a7f45bda7f5520
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.16e-04	184	115	5	8d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A RFX4 TTPA FABP7 GABRA2	1.19e-04	185	115	5	dbbd348714cd16a4948a04648e914b1e71e2a8ef
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNMB2 FLT3 PRDM1 ELFN1 NIPAL1	1.19e-04	185	115	5	ae53aa2ecfe418a5dbd7d963a995bc06dab94f56
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EOGT PDE9A ADCY3 SLCO1C1 NID1	1.19e-04	185	115	5	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A RFX4 TTPA FABP7 GABRA2	1.19e-04	185	115	5	bea69058afa5aa927fe15c1f8d46460562ec4dd4
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA TNMD LRP1 NID1 GABRA3	1.19e-04	185	115	5	785c55d39909fac74415f24427979691e7e694e6
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA TNMD LRP1 NID1 GABRA3	1.19e-04	185	115	5	97a1dcacbc48dc3f41c26fbb59af35c935f894d4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 PRDM1 JAK1 SYNE2 ARHGEF3	1.22e-04	186	115	5	71e87c4c755ab607689cb050f5a363cb520a0f53
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 NR3C2 ARHGEF3 GABRA2	1.22e-04	186	115	5	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 NR3C2 ARHGEF3 GABRA2	1.22e-04	186	115	5	08632045d499e61dd96ff29a5a9a208afe58dc58
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PALD1 PIEZO1 PKD1L3 KLHL3 NID1	1.22e-04	186	115	5	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 ADCY3 SMARCA1 LRP1	1.25e-04	187	115	5	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNMB2 FLT3 LHFPL3 PRDM1 ELFN1	1.25e-04	187	115	5	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 ADCY3 SMARCA1 LRP1	1.25e-04	187	115	5	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SYNE1 ADCY3 SMARCA1 LRP1	1.25e-04	187	115	5	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A DDX52 LHFPL3 SYNE2 TNS3	1.25e-04	187	115	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	PALD1 PDE9A ADCY3 SLCO1C1 NID1	1.25e-04	187	115	5	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 TACC2 KLHL3 EGF NR3C2	1.28e-04	188	115	5	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	JAK1 PLEKHG3 SYNE2 ADGRE5 KIR2DL1	1.28e-04	188	115	5	9abd78970bbe4ed03b59a83da63bbd334712f605
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	TRPM6 KLHL3 EGF NR3C2 ARHGEF3	1.28e-04	188	115	5	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 TACC2 KLHL3 EGF NR3C2	1.28e-04	188	115	5	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	JAK1 PLEKHG3 SYNE2 ADGRE5 KIR2DL1	1.28e-04	188	115	5	f7dc29dfec68236883469e848be5db34f5526d6b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.28e-04	188	115	5	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	JAK1 PLEKHG3 SYNE2 ADGRE5 KIR2DL1	1.28e-04	188	115	5	5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.28e-04	188	115	5	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LHFPL3 KLHL3 NR3C2 ARHGEF3 GABRA2	1.31e-04	189	115	5	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 ARHGEF3	1.31e-04	189	115	5	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 ARHGEF3	1.31e-04	189	115	5	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 ARHGEF3	1.31e-04	189	115	5	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A STAG1 SYNE1 EGF NR3C2	1.31e-04	189	115	5	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.34e-04	190	115	5	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA LHFPL3 FABP7 ELFN1 LRP1	1.34e-04	190	115	5	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 KLHL3 EGF NR3C2 ARHGEF3	1.34e-04	190	115	5	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 SLC6A16 LHFPL3 ELFN1 NIPAL1	1.38e-04	191	115	5	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA TNMD LRP1 NID1 GABRA3	1.38e-04	191	115	5	1b26056df078674f37a6c06f6256b30cfcec21a7
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA AVPR1A LRP1 NID1 GABRA3	1.41e-04	192	115	5	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TACC2 DENND4C SLC2A5 NIPAL1 G6PC2	1.41e-04	192	115	5	1304e69c92cef3bd8c82e3c035a7562f5440139a
Computational	Genes in the cancer module 396.	GABRA2 GABRA3 GABRA6	4.68e-05	12	66	3	MODULE_396
Computational	Genes in the cancer module 141.	GABRA1 GABRA2 GABRA6	1.17e-04	16	66	3	MODULE_141
Drug	Meprobamate	GABRA1 GABRA2 GABRA3 GABRA6	7.40e-09	6	109	4	DB00371
Drug	Ethchlorvynol	GABRA1 GABRA2 GABRA3 GABRA6	6.15e-08	9	109	4	DB00189
Drug	Secobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00418
Drug	Chlordiazepoxide	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00475
Drug	Metharbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00463
Drug	Pentobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00312
Drug	Talbutal	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00306
Drug	Clobazam	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00349
Drug	Butalbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00241
Drug	Butabarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00237
Drug	Bromazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01558
Drug	Barbituric acid derivative	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01496
Drug	Barbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01483
Drug	Hexobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01355
Drug	Aprobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01352
Drug	Amobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01351
Drug	Heptabarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01354
Drug	Butethal	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB01353
Drug	Methylphenobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00849
Drug	Oxazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00842
Drug	Primidone	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00794
Drug	Midazolam	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00683
Drug	Flurazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.02e-07	10	109	4	DB00690
Drug	Zolpidem	GABRA1 GABRA2 GABRA3	1.07e-07	3	109	3	DB00425
Drug	Aa1	STAG1 SYNE1 KIR2DL1 KIR2DS1 KIR2DS3 KIR2DS4 KIR2DS5	1.46e-07	83	109	7	CID009549188
Drug	Thiopental	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00599
Drug	Alprazolam	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00404
Drug	Temazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00231
Drug	Nitrazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB01595
Drug	Lorazepam	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00186
Drug	Phenobarbital	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB01174
Drug	Triazolam	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00897
Drug	Clorazepate	GABRA1 GABRA2 GABRA3 GABRA6	1.60e-07	11	109	4	DB00628
Drug	3-isothujone	ALPK2 GABRA1 GABRA2 GABRA3 GABRA6	2.97e-07	30	109	5	CID000011027
Drug	Flumazenil	GABRA1 GABRA2 GABRA3	4.25e-07	4	109	3	DB01205
Drug	Eszopiclone	GABRA1 GABRA2 GABRA3	1.06e-06	5	109	3	DB00402
Drug	Zopiclone	GABRA1 GABRA2 GABRA3	1.06e-06	5	109	3	DB01198
Drug	Lorazepam	GABRA1 GABRA2 GABRA3	1.06e-06	5	109	3	ctd:D008140
Drug	dihydroxyaflavinine	GABRA1 GABRA2 GABRA3 GABRA6	1.13e-06	17	109	4	CID000156857
Drug	Gabrene	ADGRE5 GABRA1 GABRA2 GABRA3 GABRA6	1.32e-06	40	109	5	CID005361323
Drug	Flunitrazepam	GABRA2 GABRA3 GABRA6	2.11e-06	6	109	3	DB01544
Drug	Quazepam	GABRA1 GABRA2 GABRA3	3.68e-06	7	109	3	DB01589
Drug	baclofen	GPRC6A PKD1L3 ADCY3 EGF GABRA1 GABRA2 GABRA3 GABRA6	3.90e-06	191	109	8	CID000002284
Drug	zolazepam	TNMD GABRA1 GABRA2 GABRA6	4.10e-06	23	109	4	CID000035775
Drug	methohexital	GABRA1 GABRA2 GABRA3 GABRA6	4.91e-06	24	109	4	CID000009034
Drug	Adinazolam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB00546
Drug	Fludiazepam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB01567
Drug	Clotiazepam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB01559
Drug	Cinolazepam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB01594
Drug	Prazepam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB01588
Drug	Estazolam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB01215
Drug	Halazepam	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	DB00801
Drug	1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane	GABRA1 GABRA2 GABRA3	5.87e-06	8	109	3	ctd:C091518
Drug	AC1Q5UBL	COMT SLC6A16 ADGRE5 GABRA1 GABRA2 GABRA3 GABRA6	6.66e-06	146	109	7	CID000005466
Drug	Diazepam	GABRA1 GABRA2 GABRA3	8.78e-06	9	109	3	DB00829
Drug	tiotidine	GABRA1 GABRA2 GABRA3	8.78e-06	9	109	3	ctd:C023990
Drug	mephobarbital	TNMD GABRA1 GABRA2 GABRA6	9.31e-06	28	109	4	CID000008271
Drug	AC1L1BIT	RAF1 SYNE1 GABRA1 GABRA2 GABRA6	1.02e-05	60	109	5	CID000001457
Drug	etazolate	ADCY3 GABRA1 GABRA2 GABRA6	1.08e-05	29	109	4	CID000003277
Drug	AC1L1FKW	GABRA1 GABRA2 GABRA6	1.25e-05	10	109	3	CID000003281
Drug	Clonazepam	GABRA1 GABRA2 GABRA3	1.25e-05	10	109	3	DB01068
Drug	beta-carboline	SYNE1 GABRA1 GABRA2 GABRA3 GABRA6	1.40e-05	64	109	5	CID000064961
Drug	picrotoxinine	CTBS GABRA1 GABRA2 GABRA3 GABRA6	1.51e-05	65	109	5	CID000004816
Drug	deoxycorticosterone	PALD1 COMT NR3C2 GABRA1 GABRA2 GABRA6	1.58e-05	111	109	6	CID000006166
Drug	fosazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000037114
Drug	C19H18ClN3O	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000027452
Drug	flutoprazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000003400
Drug	Arfendazam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000065803
Drug	camazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000037367
Drug	Bu-1014	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID015942721
Drug	Zapizolam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000068832
Drug	Reclazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID003052777
Drug	iclazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000068777
Drug	menitrazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000189875
Drug	Serin hydrazid	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000041637
Drug	sulazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000017931
Drug	elfazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000065445
Drug	triflubazam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000031157
Drug	uldazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000034274
Drug	gidazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000121919
Drug	fletazepam	GABRA1 GABRA2 GABRA6	1.71e-05	11	109	3	CID000036834
Drug	CGS 8216	GABRA1 GABRA2 GABRA3 GABRA6	1.83e-05	33	109	4	CID000104916
Drug	AC1L2FYN	GABRA1 GABRA2 GABRA3 GABRA6	1.83e-05	33	109	4	CID000071333
Drug	felbamate	ADGRE5 GABRA1 GABRA2 GABRA3 GABRA6	2.17e-05	70	109	5	CID000003331
Drug	SB-205384	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000197690
Drug	U-93631	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000197626
Drug	haloxazolam	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000003563
Drug	doxefazepam	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000038668
Drug	pivoxazepam	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000068722
Drug	razobazam	GABRA1 GABRA2 GABRA6	2.28e-05	12	109	3	CID000071228
Drug	flurazepam	GABRA1 GABRA2 GABRA3 GABRA6	2.32e-05	35	109	4	CID000003393
Drug	quinazoline	FLT3 PDGFRA SYNE1 JAK1 EGF	2.32e-05	71	109	5	CID000009210
Drug	secobarbital	GABRA1 GABRA2 GABRA3 GABRA6	2.91e-05	37	109	4	CID000005193
Drug	nerisopam	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID000065875
Drug	flutazolam	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID000003398
Drug	4-PIOL	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID000125520
Drug	AC1MVFYM	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID003707225
Drug	Ro 11-3128	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID000093364
Drug	cinolazepam	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID003033621
Drug	alpha IMGBL	GABRA1 GABRA2 GABRA6	2.95e-05	13	109	3	CID000131516
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.34e-32	46	121	18	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.16e-28	69	121	18	DOID:1682 (implicated_via_orthology)
Disease	Hypereosinophilic syndrome	PDGFRA JAK1	9.95e-05	4	121	2	C1540912
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	9.95e-05	4	121	2	cv:CN293514
Disease	Autistic Disorder	DPYD COMT AVPR1A EGF GABRA1 GABRA2 GABRA3	1.05e-04	261	121	7	C0004352
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	1.65e-04	5	121	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	1.65e-04	5	121	2	C0410190
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	2.47e-04	6	121	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	2.47e-04	6	121	2	C0410189
Disease	Cannabis use	COMT GABRA2	2.47e-04	6	121	2	C3160814
Disease	interleukin-23 receptor measurement	ARHGEF3 IL23R	2.47e-04	6	121	2	EFO_0801725
Disease	gallbladder cancer (is_marker_for)	DPYD EGF	3.46e-04	7	121	2	DOID:3121 (is_marker_for)
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	3.46e-04	7	121	2	C0751337
Disease	endometrial cancer (is_implicated_in)	COMT JAK1 EGF	4.35e-04	36	121	3	DOID:1380 (is_implicated_in)
Disease	pseudohypoaldosteronism (is_implicated_in)	KLHL3 NR3C2	4.59e-04	8	121	2	DOID:4479 (is_implicated_in)
Disease	Cutaneous Melanoma	RAF1 ERCC3 PDGFRA	6.40e-04	41	121	3	C0151779
Disease	Pseudohypoaldosteronism, Type I	KLHL3 NR3C2	7.35e-04	10	121	2	C0268436
Disease	Pseudohypoaldosteronism	KLHL3 NR3C2	7.35e-04	10	121	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	KLHL3 NR3C2	7.35e-04	10	121	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	KLHL3 NR3C2	7.35e-04	10	121	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	KLHL3 NR3C2	7.35e-04	10	121	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	KLHL3 NR3C2	7.35e-04	10	121	2	C1449842
Disease	alpha wave measurement, electroencephalogram measurement	DNAH1 TNS3	7.35e-04	10	121	2	EFO_0004357, EFO_0006870
Disease	Bipolar Disorder	PDE9A COMT SYNE1 RFX4 ADCY3 FABP7 GABRA1 GABRA3	8.05e-04	477	121	8	C0005586
Disease	pancreatic cancer (is_marker_for)	DPYD PDGFRA EGF ADGRE5	8.08e-04	101	121	4	DOID:1793 (is_marker_for)
Disease	Alcoholic Intoxication, Chronic	COMT RFX4 EGF GABRA1 GABRA2 GABRA6	8.53e-04	268	121	6	C0001973
Disease	T-cell acute lymphoblastic leukemia (is_implicated_in)	PDGFRA JAK1	8.95e-04	11	121	2	DOID:5603 (is_implicated_in)
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 SYNE2	1.07e-03	12	121	2	DOID:11726 (implicated_via_orthology)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	PDGFRA LRP1	1.07e-03	12	121	2	DOID:3827 (implicated_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	ARHGEF3 KIR2DS4	1.07e-03	12	121	2	EFO_0008197
Disease	pancreatic adenocarcinoma (is_implicated_in)	RAF1 JAK1	1.69e-03	15	121	2	DOID:4074 (is_implicated_in)
Disease	pro-hydroxy-pro measurement	TRPM6 NR3C2	1.93e-03	16	121	2	EFO_0021132
Disease	sphingomyelin 14:0 measurement	SYNE2 NID1	2.18e-03	17	121	2	EFO_0010390
Disease	heart rate	PDE9A LHFPL3 RFX4 NR3C2 TNS3	2.39e-03	225	121	5	EFO_0004326
Disease	Alcohol abuse	COMT GABRA1 GABRA2	2.66e-03	67	121	3	C0085762
Disease	cardiomyopathy (implicated_via_orthology)	RAF1 ASAH2 LRP1	3.14e-03	71	121	3	DOID:0050700 (implicated_via_orthology)
Disease	Precursor B-cell lymphoblastic leukemia	FLT3 PDGFRA	3.33e-03	21	121	2	C1292769
Disease	haptoglobin measurement	DHX38 PKD1L3	3.33e-03	21	121	2	EFO_0004640
Disease	Mental Depression	COMT SLCO1C1 NR3C2 GABRA3 GABRA6	4.02e-03	254	121	5	C0011570
Disease	IGF-1 measurement	STAG1 AVPR1A BAZ1B OGDH JAK1 SYNE2 CFAP61	4.06e-03	488	121	7	EFO_0004627

Protein segments in the cluster

Peptide	Gene	Start	Entry
MFSATFAYDVEQWCK	DDX52	351	Q9Y2R4
VCSYVDMGWTDTLES	EOGT	96	Q5NDL2
KDYALMSLCSWVNVV	CFAP61	726	Q8NHU2
TCSSKWMSVQYFEKL	CEP152	1076	O94986
ANLIEVVMASSFWEC	ELFN1	141	P0C7U0
SKLWSETFDVCVNQM	ARHGEF3	101	Q9NR81
ECSDVMTDYSNAVWQ	ALPK2	331	Q86TB3
TWMDKLVVEYANAIC	ABHD2	391	P08910
AWLEIMTKYAVGEEC	BAZ1B	106	Q9UIG0
EKAEWMTTTCNHALY	ARFGEF1	1446	Q9Y6D6
VEKYEATSTSWQIVC	ASAH2B	81	P0C7U1
ITTKQSIYVCCIVWM	GPR34	166	Q9UPC5
MVKVFSSEAAWQCVS	ACAD9	381	Q9H845
QKDTVCEDMTFSTWT	ADGRE5	251	P48960
IVIASIMCSYNKNDW	DPYD	636	Q12882
MEAVWKTEVASSSYA	FAM186B	851	Q8IYM0
VMSYDEQSQIWSECI	CTBS	206	Q01459
FQLLVTYAWCSEEEM	CST9	21	Q5W186
YMTKDNLAIVTQWCE	RAF1	411	P04049
VAQEMKAEYWAVSSL	RAB34	186	Q9BZG1
SYIEWLDTMVDRCVV	RFX4	396	Q33E94
ECLMQSKFYIASDVW	JAK1	1051	P23458
STWMQEVASKAGIYE	PALD1	801	Q9ULE6
ATSEVYEIMVKCWNS	PDGFRA	921	P16234
SEETVILQCWSDVMF	KIR2DS4	41	P43632
RSYMQSVWTEESQCT	KCNMB2	71	Q9Y691
EDQITLIQYSWMCLS	NR3C2	796	P08235
ESWYRSKCEEMKATV	KRT85	311	P78386
TAMDFSYANETVCWV	LRP1	231	Q07954
VEKYEATSTSWQIVC	ASAH2	696	Q9NR71
SITYTTVDWRDFMCN	KIAA1109	4911	Q2LD37
MEWTSYTVAVKTSDI	LOXHD1	1676	Q8IVV2
KVAYATAMDWFIAVC	GABRA2	306	P47869
IMTVWNKSKVCSYSS	KIAA0232	191	Q92628
TSILVDMWYQTVNTC	NXF5	336	Q9H1B4
SMVWLCSLQEKFSQT	PDE9A	326	O76083
DCVDKMVYWTDITEP	NID1	986	P14543
VSWMEEQLSYFCDKC	KAT14	66	Q9H8E8
WSAAVVVHDCIYVMT	KBTBD2	421	Q8IY47
KKVTWYEALNMCSQS	LY75	1411	O60449
ESWYRSKCEEMKATV	KRT87P	126	A6NCN2
SEETVILQCWSDVMF	KIR2DS3	41	Q14952
KVAYATAMDWFIAVC	GABRA3	331	P34903
KVAYATAMDWFIAVC	GABRA1	306	P14867
KVSYATAMDWFIAVC	GABRA6	296	Q16445
VEILTTHCDSYWVEM	NLRP2	56	Q9NX02
THCDSYWVEMASLQV	NLRP2	61	Q9NX02
SCSEDKYVTSAYQWM	NBAS	921	A2RRP1
SEETVILQCWSDVMF	KIR2DS5	41	Q14953
STMCFEKEVEYLNWN	GPRC6A	576	Q5T6X5
YLWKMTVDASENVQC	HERC5	611	Q9UII4
EAVMYVCKVAAEWRS	OGDH	481	Q02218
LEAIDTYCEQKEWAM	COMT	76	P21964
EEIYIIMQSCWAFDS	FLT3	916	P36888
VTIAGCQTYWTMEVA	DNAH1	1436	Q9P2D7
CQTYWTMEVAEALEA	DNAH1	1441	Q9P2D7
LSIAEMYSSVADQWC	KLHL18	491	O94889
LYWCDAKQSVIEMAN	EGF	656	P01133
TGSYWCEAQTMASKV	FCRL1	81	Q96LA6
MSCTRSVYSWDIVVQ	EIF3D	256	O15371
VDLSCDYQFWMQKLS	FANCC	6	Q00597
YWDSQTTIEKVSCEM	IL23R	241	Q5VWK5
VSCEMRYKATTNQTW	IL23R	251	Q5VWK5
TVASKMWVAVASAYS	DENND4C	1371	Q5VZ89
QYDVWSTDVTVANKM	ADCY3	431	O60266
KEYSTAVDMWSVGCI	CDK11A	601	Q9UQ88
CVWYVMVTAALSHTV	G6PC2	121	Q9NQR9
VYDGVKDQWTSIASM	KLHL3	366	Q9UH77
DVVRASTFSCIMQKW	HAS3	176	O00219
AQFKMWSTIDDSQIC	ERCC3	376	P19447
MVEAFCATWKLTNSQ	FABP7	1	O15540
SEETVILQCWSDVMF	KIR2DL1	41	P43626
SMVVTCSAILFQEWY	NIPAL1	316	Q6NVV3
VSPEDFCEKMWINYT	OTOGL	1756	Q3ZCN5
MKEDVLAYVFDSVWC	FAM149B1	266	Q96BN6
DSVWCKVVSCMEQLT	FAM149B1	276	Q96BN6
SEETVILQCWSDVMF	KIR2DS1	41	Q14954
MKHTYINVWTEECEG	TAS2R20	146	P59543
FDTYSSWNILCKIIM	TAS2R40	271	P59535
VVAKISDVYNMSVWS	SLC6A16	326	Q9GZN6
GEWDVCVTSYEMVIK	SMARCA1	281	P28370
ITTWFTKVEESLMNC	SYNE1	2316	Q8NF91
QEQVWAEMCSIKAVT	SYNE2	3196	Q8WXH0
MIKQFQSTVETWDQC	SYNE2	5801	Q8WXH0
CMKTVAGSAWTYNTT	RPL37AP8	61	A6NKH3
EDAIDTMTCVAWYIN	PLEKHG3	256	A1L390
QDTVSWMPYISIVCV	SLC2A5	366	P22732
SWYVSQVIVCDMAVK	PKD1L3	821	Q7Z443
MTLWTEAEFEEKCTY	PRDM1	46	O75626
WDVMSNEELCEYVKS	PPM1B	246	O75688
CNVWYLNSVEMESLT	TNS3	1311	Q68CZ2
LTWEESKQYCTDMNA	CLEC1B	121	Q9P126
VCAKYGWVTVECDML	ZC3HC1	101	Q86WB0
NSKILEICDNVTMYW	TNMD	171	Q9H2S6
WYKMDDAEVTVCSIT	USP17L3	346	A6NCW0
QLWCKMSSSVISYQD	ZWILCH	351	Q9H900
GETDFCMSKWEEIIY	XKR7	346	Q5GH72
CHSANQWLTIEKYMT	TRPM6	1866	Q9BX84
WYKMDDAEVTVCSIT	USP17L4	346	A6NCW7
VKPCVVDWTSQYTMV	ZDHHC13	596	Q8IUH4
NECEVDTSSSMWIYV	SLCO1C1	176	Q9NYB5
WYKMDDAEVTASSIT	USP17L18	346	D6R9N7
KYESEWTNEVSMVLT	EXT2	581	Q93063
WYKMDDAEVTASSIT	USP17L5	346	A8MUK1
WYKMDDAEVTASSIT	USP17L21	346	D6R901
WYKMDDAEVTAASIT	USP17L13	346	C9JLJ4
CLTWTQYASMKEESV	PRELID2	111	Q8N945
SAMQSVVDDWIESYK	STAG1	96	Q8WVM7
WYKMDDAEVTASSIT	USP17L19	346	D6RCP7
TKEYMQCVTAVDGEW	DHX38	1126	Q92620
VTNQKWTCMTVDLEA	TACC2	2476	O95359
WTCMTVDLEADKQDY	TACC2	2481	O95359
WYKMDDAEVTVCSII	USP17L1	346	Q7RTZ2
CQEWTNFIMKSEDYL	TTPA	256	P49638
ETVKYCVDVYTDWIM	RALGAPB	81	Q86X10
KMTFVIVTAYIVCWA	AVPR1A	291	P37288
WYKMDDAEVTASSIT	USP17L12	346	C9JPN9
VDFSKQYSASWMCLS	TMEM19	161	Q96HH6
WYKMDDAEVTASSIT	USP17L24	346	Q0WX57
WYKMDDAEVTACSIT	USP17L8	346	P0C7I0
LSLSSWMCVEDIYAN	PIEZO1	2131	Q92508
WYKMDDAEVTASSIT	USP17L6P	346	Q6QN14
WYKMDDAEVTASSIT	USP17L22	346	D6RA61
WYKMDDAEVTASSIT	USP17L15	346	C9J2P7
WYKMDDAEVTAASIT	USP17L17	346	D6RBQ6
YEVTSSQWVRMEKCH	ZNF850	96	A8MQ14
VKSSYSMENANKWSC	ZRANB1	76	Q9UGI0
WYKMDDAEVTASSIT	USP17L20	346	D6RJB6
WYKMDDAEVTASSIT	USP17L10	346	C9JJH3
WYKMDDAEVTASSIT	USP17L11	346	C9JVI0
SVLIDQYVSTKESWM	VPS13D	2806	Q5THJ4
QYVSTKESWMADYCK	VPS13D	2811	Q5THJ4
TVYKICAWMQLTSAA	LHFPL3	136	Q86UP9